Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes - a cross-sectional study.

IF 2.7 3区 医学 Q3 ONCOLOGY Acta Oncologica Pub Date : 2024-06-30 DOI:10.2340/1651-226X.2024.40141
Ninna Aggerholm-Pedersen, Lise Bech Jellesmark Thorsen, Nina Møller Tauber, Josefine Tingdal Danielsen, Katrine Løppenthin, Signe Borgquist, Christoffer Johansen, Robert Zacharie
{"title":"Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes - a cross-sectional study.","authors":"Ninna Aggerholm-Pedersen, Lise Bech Jellesmark Thorsen, Nina Møller Tauber, Josefine Tingdal Danielsen, Katrine Løppenthin, Signe Borgquist, Christoffer Johansen, Robert Zacharie","doi":"10.2340/1651-226X.2024.40141","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>The study aims to investigate the impact of the COVID-19 pandemic on cancer patients' perceptions of the quality of their oncological treatment and care.</p><p><strong>Background: </strong>The COVID-19 pandemic disrupted healthcare delivery and oncological resources were repurposed, potentially leading to prolonged treatment and reduced access to innovative therapies and clinical trials. Still, little is known about how patients perceived the quality of their treatment.</p><p><strong>Methods: </strong>A cross-sectional study was conducted in the spring of 2020 among cancer patients at the Department of Oncology, Aarhus University Hospital and Rigshospitalet, Denmark. Patients were invited to complete an online questionnaire on clinical, socioeconomic, emotional, behavioural, and quality-related aspects of oncological cancer care. Patients who experienced reduced treatment quality and those who reported no or slight reductions were compared using multiple logistic regression, exploring the associations with patient characteristics, behaviours, and fear of cancer progression or recurrence.</p><p><strong>Results: </strong>A total of 2,040/5,372 patients experienced changes in their treatment plans during the pandemic, and 1,570/5,372 patients experienced reduced treatment quality, with 236 reporting a high degree of reduction. Patients with breast, head and neck, and upper gastrointestinal cancers were more likely to experience reduced treatment quality. Altered interactions with healthcare providers, along with isolation, lack of social support, and heightened fear of cancer progression, were significant risk factors for experiencing reduced cancer care quality.</p><p><strong>Interpretation: </strong>We identified subgroups of cancer patients needing targeted communication and care during health crises affecting cancer treatment. The findings underscore the importance of safeguarding the needs of vulnerable patient populations in future healthcare emergencies.</p>","PeriodicalId":7110,"journal":{"name":"Acta Oncologica","volume":"63 ","pages":"518-525"},"PeriodicalIF":2.7000,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11332494/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Oncologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2340/1651-226X.2024.40141","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: The study aims to investigate the impact of the COVID-19 pandemic on cancer patients' perceptions of the quality of their oncological treatment and care.

Background: The COVID-19 pandemic disrupted healthcare delivery and oncological resources were repurposed, potentially leading to prolonged treatment and reduced access to innovative therapies and clinical trials. Still, little is known about how patients perceived the quality of their treatment.

Methods: A cross-sectional study was conducted in the spring of 2020 among cancer patients at the Department of Oncology, Aarhus University Hospital and Rigshospitalet, Denmark. Patients were invited to complete an online questionnaire on clinical, socioeconomic, emotional, behavioural, and quality-related aspects of oncological cancer care. Patients who experienced reduced treatment quality and those who reported no or slight reductions were compared using multiple logistic regression, exploring the associations with patient characteristics, behaviours, and fear of cancer progression or recurrence.

Results: A total of 2,040/5,372 patients experienced changes in their treatment plans during the pandemic, and 1,570/5,372 patients experienced reduced treatment quality, with 236 reporting a high degree of reduction. Patients with breast, head and neck, and upper gastrointestinal cancers were more likely to experience reduced treatment quality. Altered interactions with healthcare providers, along with isolation, lack of social support, and heightened fear of cancer progression, were significant risk factors for experiencing reduced cancer care quality.

Interpretation: We identified subgroups of cancer patients needing targeted communication and care during health crises affecting cancer treatment. The findings underscore the importance of safeguarding the needs of vulnerable patient populations in future healthcare emergencies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于患者报告结果的 COVID-19 大流行期间肿瘤治疗质量的变化 - 一项横断面研究。
目的:本研究旨在调查 COVID-19 大流行对癌症患者对其肿瘤治疗和护理质量看法的影响:背景:COVID-19 大流行扰乱了医疗保健服务,肿瘤资源被挪作他用,可能导致治疗时间延长、获得创新疗法和临床试验的机会减少。然而,人们对患者如何看待治疗质量却知之甚少:丹麦奥胡斯大学医院(Aarhus University Hospital)肿瘤科和里格医院(Rigshospitalet)于 2020 年春季对癌症患者进行了一项横断面研究。患者应邀填写了一份在线问卷,内容涉及肿瘤治疗的临床、社会经济、情感、行为和质量相关方面。采用多元逻辑回归法比较了治疗质量下降的患者和没有或略有下降的患者,探讨了与患者特征、行为以及对癌症进展或复发的恐惧之间的关联:共有 2,040/5,372 名患者在大流行期间改变了治疗计划,1,570/5,372 名患者的治疗质量有所下降,其中 236 名患者的治疗质量下降程度较高。乳腺癌、头颈部癌症和上消化道癌症患者的治疗质量更容易下降。与医疗服务提供者之间的互动改变,以及孤立、缺乏社会支持和对癌症进展的恐惧加剧,都是导致癌症治疗质量下降的重要风险因素:我们发现了在影响癌症治疗的健康危机期间需要针对性沟通和护理的癌症患者亚群。这些发现强调了在未来的医疗紧急状况中保障弱势患者群体需求的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Oncologica
Acta Oncologica 医学-肿瘤学
CiteScore
4.30
自引率
3.20%
发文量
301
审稿时长
3 months
期刊介绍: Acta Oncologica is a journal for the clinical oncologist and accepts articles within all fields of clinical cancer research. Articles on tumour pathology, experimental oncology, radiobiology, cancer epidemiology and medical radio physics are also welcome, especially if they have a clinical aim or interest. Scientific articles on cancer nursing and psychological or social aspects of cancer are also welcomed. Extensive material may be published as Supplements, for which special conditions apply.
期刊最新文献
Patient reported experiences of health care, quality of life and preoperative information in colon cancer. Survival outcomes for HER2-low breast cancer: Danish national data. The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study. NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial. The impact of age on clinicopathological features and treatment results in patients with localised prostate cancer receiving definitive radiotherapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1